Aminorroaya Ashraf, Janghorbani Mohsen, Amini Masoud, Hovsepian Silva, Tabatabaei Azamosadat, Fallah Zahra
Isfahan Endocrine and Metabolism Research Center, School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran.
Arch Iran Med. 2009 May;12(3):262-70.
The prevalence of hypothyroidism in Iran is unknown. The aims of the present study were to estimate the prevalence of overt and subclinical hypothyroidism among the adult population of Isfahan, a large metropolitan city in Iran, 15 years after universal salt iodization.
A cross-sectional survey was conducted from January 2006 through April 2006. The selection was conducted by stratified probability cluster sampling through household family members in Isfahan, Iran. Thyroid stimulating hormone (TSH) of 2523 men and women aged >20 years (mean: 39.0) was measured. Additional thyroid tests were done and serum levels of antithyroid antibodies were evaluated in individuals with elevated TSH. Elevated TSH with normal free T4 index (FT4I) at the second measurement was considered as subclinical and high TSH with low FT4I as overt hypothyroidism.
The overall prevalence of hypothyroidism was 4.8% [95% confidence interval (CI) 3.7, 6.1] in men and 12.8% (95% CI 10.9, 14.6) in women; and 37.6% of hypothyroid men and women had positive antithyroperoxidase antibodies and/or antithyroglobulin antibody, while 19.3% of men and women were euthyroid. The mean (SE) of urinary iodine was 20.3 (0.55) microg/dL and 20.1 (1.37) microg/dL for euthyroid and hypothyroid individuals, respectively (P=0.65). Older age, female sex, and goiter were strongly associated with both overt and subclinical hypothyroidism.
Hypothyroidism appears to be common in Isfahan, Iran. The high prevalence of hypothyroidism in Isfahan may be due to autoimmunity with no correlation to iodine intake.
伊朗甲状腺功能减退症的患病率尚不清楚。本研究的目的是在全民食盐加碘15年后,估计伊朗大城市伊斯法罕成年人群中显性和亚临床甲状腺功能减退症的患病率。
2006年1月至2006年4月进行了一项横断面调查。通过对伊朗伊斯法罕的家庭成员进行分层概率整群抽样来选择研究对象。测量了2523名年龄大于20岁(平均39.0岁)的男性和女性的促甲状腺激素(TSH)。对TSH升高的个体进行了额外的甲状腺检查,并评估了抗甲状腺抗体的血清水平。第二次测量时TSH升高且游离T4指数(FT4I)正常被视为亚临床甲状腺功能减退,TSH高且FT4I低被视为显性甲状腺功能减退。
男性甲状腺功能减退症的总体患病率为4.8%[95%置信区间(CI)3.7, 6.1],女性为12.8%(95%CI 10.9, 14.6);37.6%的甲状腺功能减退男性和女性抗甲状腺过氧化物酶抗体和/或抗甲状腺球蛋白抗体呈阳性,而19.3%的男性和女性甲状腺功能正常。甲状腺功能正常和甲状腺功能减退个体的尿碘均值(SE)分别为20.3(0.55)μg/dL和20.1(1.37)μg/dL(P = 0.65)。年龄较大、女性和甲状腺肿与显性和亚临床甲状腺功能减退症均密切相关。
甲状腺功能减退症在伊朗伊斯法罕似乎很常见。伊斯法罕甲状腺功能减退症的高患病率可能是由于自身免疫,与碘摄入量无关。